CTN Protocols

Number Title Status
CTN-0150 Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME) for pregnant and postpartum persons in MOUD in development
CTN-0149 Trajectories of Secondary Outcomes in CTN Trials in development
CTN-0148 Cocaine Craving and Use Outcomes Secondary Analysis of a Randomized Study to Test the Safety and Effectiveness of Buprenorphine in the Presence of Naltrexone for the Treatment of Cocaine Dependence active
CTN-0147 Building Opioid recovery support Networks to engage and retain young adults in Medication for Opioid Use Disorder (BOND) (NIH HEAL Initiative) in development
CTN-0146 Adolescent outcomes of Post-operative opioid Exposure (APEX) (NIH HEAL Initiative) in development
CTN-0145 Standard versus High Dose ED-Initiated Buprenorphine Induction (NIH HEAL Initiative) in development
CTN-0144 Better Together: Integrating MOUD in African American Community Settings (NIH HEAL Initiative) in development
CTN-0143 Social Determinants of Health (SDOH); Needs and Consequences Associated with Substance Use Disorders active
CTN-0142 Towards Personalized Medicine in Medication for Opioid Use Disorder (MOUD): Analyses of Veterans Health Administration Data to Delineate Patient Characteristics Associated with Treatment Outcomes and Successful MOUD Discontinuation in development
CTN-0141 Health Insurance Instability and Mortality among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder: Linkage of the Prescription Opioid Registry with the National Death Index active
CTN-0140 Cannabis Use among Pregnant Women with Polysubstance Use and Psychiatric Problems completed
CTN-0139 Collaborative Care for Polysubstance use in Primary Care Settings (Co-Care) (NIH HEAL Initiative) in development
CTN-0138 Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool in development
CTN-0137 Multi-Level Stigma Intervention to Improve Access to Substance Use Care with Prescribing Providers in Mental Health Settings in development
CTN-0136 Medication for Opioid Use Disorder, Predictability of Retention vs. Attrition active
CTN-0135 Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl active
CTN-0134 Buprenorphine-Precipitated Withdrawal Hotspots and Correlates completed
CTN-0133 Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials (NIH HEAL Initiative) active
CTN-0132 Ketamine for Methamphetamine use Disorder (KMD) Study in development
CTN-0131 Office-Based Methadone versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder (MOUD)-- A Pragmatic Hybrid Effectiveness/Implementation Trial in development
CTN-0130 Quantifying How Cocaine Users Respond to Fentanyl Contamination in Cocaine completed
CTN-0129 The Great Plains Initiative active
CTN-0128 Adherence and Feasibility of Wearable Technologies and Ecological Momentary Assessment to Assess Autonomic Function and Negative Affect in Opioid Use Disorder active
CTN-0127 Engaging African American Faith-Based Leaders in a Substance Use Learning Collaborative active
CTN-0126 Longitudinal Follow-Up of Individuals with Opioid Use Disorder active
CTN-0125 Integrative Data Analysis of CTN Studies to Examine the Impact of Psychosocial Treatments for Black People who use Cocaine active
CTN-0124 Assessment and Design of a Cost-Effective Collaborative MOUD Delivery System completed
CTN-0123 Facebook Intervention for Preventing Opioid Relapse among American Indian Women active
CTN-0122 Comprehensive Meta-Analysis of CTN Treatment Outcomes by Race and Sex active
CTN-0121 Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (SUD) among Hospitalized Patients in development
CTN-0120 R-MIST: Remote Methadone Ingestion Surveillance Trial in development
CTN-0119 Impact of Social Distancing Measures, Expansion of Telemedicine for Buprenorphine Prescribing, and Health Insurance Payor on Access to Buprenorphine During the COVID-19 Pandemic completed
CTN-0118 Examining the COVID-19 Public Health Emergency on Policy, Substance Use Disorder, Treatment and Resilience among American Indian and Alaska Native Communities active
CTN-0117 The Impact of COVID-19 Pandemic on Substance Use Treatment Services completed
CTN-0116 Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder active
CTN-0115 Developing an Intervention to Address Intersecting Prescription Opioid and Chronic Pain Stigma in Cancer Survivors (NIH HEAL Initiative) completed
CTN-0114 Drug Repurposing for Cocaine Use Disorder (CUD) Using a Combined Strategy of Artificial Intelligence (AI)-Based Prediction and Retrospective Clinical Corroboration completed
CTN-0113 Validating a DSM-5 Substance Use Disorder (SUD) Symptom Checklist in EHR Data from a Large Primary Care Sample to Support Future Pragmatic Trials and Chronic Care Management of SUDs in Primary Care completed
CTN-0112 Optimal Policies to Improve Methadone Maintenance Adherence Longterm (OPTIMMAL) completed
CTN-0111 COVID-19 and Substance Misuse Case Identification using Data Science: A Retrospective Cohort Study completed
CTN-0110 Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine For Methamphetamine Use Disorder (MURB) active
CTN-0109 Randomized, Placebo-controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2) active
CTN-0109-A-1: Innovative Development of Research Engagement Manual (I-DREM): Strategies to Enhance Recruitment and Retention of Black Individuals in CTN-0109 CURB-2 active
CTN-0108 Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder active
CTN-0107 Peer Intervention to Link Overdose survivors to Treatment (PILOT) (NIH HEAL Initiative) active
CTN-0106 Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor (NIH HEAL Initiative) completed
CTN-0105 Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders (NIH HEAL Initiative) completed
CTN-0104 Healthcare Provider Stigma Related to the Opioid Use Epidemic and its Impact on Patient Treatment and Clinical Management (NIH HEAL Initiative) completed
CTN-0103 Expanding Clinical Research Training on Implementing the Evidence-based Hub and Spoke Model of Medication-Assisted Treatment for Opioid Use Disorder (NIH HEAL Initiative) completed
CTN-0102 Rural Expansion of Medication Treatment for Opioid Use Disorder (NIH HEAL Initiative) completed
CTN-0102-A-1: COVID Impact on Rural Expansion of Medication Treatment for Opioid Use Disorder completed
CTN-0102-C: Rural Expansion of Medication Treatment for Opioid Use Disorder: Electronic Health Record Data Collection (NIH HEAL Initiative) completed
CTN-0102-XR: Rural Expansion of Medication Treatment for Opioid Use Disorder: Randomized Controlled Pilot Trial of Extended-release Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings (NIH HEAL Initiative) in development
CTN-0101 Subthreshold Opioid Use Disorder Prevention (STOP) Trial (NIH HEAL Initiative) active
CTN-0100 Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (NIH HEAL Initiative) active
CTN-0099 Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative) active
CTN-0098 Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE) (NIH HEAL Initiative) active
CTN-0097 Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (NIH HEAL Initiative) completed
CTN-0096 Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative) active
CTN-0096-A-1: National Medication-Assisted Treatment Survey of Substance Use Disorder Programs Serving American Indian and Alaska Native People active
CTN-0095 Clinic-Randomized Trial of Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUT 2.0) (NIH HEAL Initiative) active
CTN-0095-A-1: Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder completed
CTN-0095-A-2: Reducing Stigma Toward People with Opioid Use Disorder Among Primary Care Clinicians completed
CTN-0094 Individual Level Predictive Modeling of Opioid Use Disorder Treatment Outcome (NIH HEAL Initiative) completed
CTN-0093 Validation of a Community Pharmacy-based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN) (NIH HEAL Initiative) completed
CTN-0091 Preventing and Identifying Opioid Use Disorder Using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management (NIH HEAL Initiative) completed
CTN-0090 Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution (NIH HEAL Initiative) completed
CTN-0089 Integrating Nurse Practitioner Buprenorphine Waiver Training into Graduate Nursing Curriculum (NIH HEAL Initiative) completed
CTN-0088 DC Research Infrastructure Building & Initiative to Reach, Engage, and Retain in MAT Patients with OUD (NIH HEAL Initiative) completed
CTN-0087 A Foundation to Examine Reasons for Discontinuation for Buprenorphine Care in the Veterans Health Administration (NIH HEAL Initiative) completed
CTN-0086 Inpatient versus Outpatient Treatment Outcomes for People with Opioid Use Disorder (NIH HEAL Initiative) completed
CTN-0085 Selection Bias Free Estimation of the Impact of Drug-Focused Twelve Step Mutual Help Groups Using the VA Database (NIH HEAL Initiative) completed
CTN-0084 Developing a Prescription Opioid Registry across Diverse Health Systems (NIH HEAL Initiative) completed
CTN-0084-A-1: Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality completed
CTN-0084-A-2: Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT) completed
CTN-0083 Using Social Media to Deliver HIV Self-Testing Kits and Link to Online PrEP Services completed
CTN-0082 Implementation Survey of PrEP and Opioid Use Related Services In STI Clinics and Community Based Organizations (CBOs) completed
CTN-0082-A-1: COVID-19 Vaccine Readiness in People Who Use Substances In Community STI Clinics and Substance Use Intervention or Harm Reduction Programs In Eight Higher HIV Incidence Southeastern Cities completed
CTN-0081 Emergency Medicine Opioid Data Infrastructure: Key Venue to Address Opioid Morbidity and Mortality (Project CODE PRO–Capturing Opioid Use Disorder Electronically and Patient Reported Outcomes) completed
CTN-0080 Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs) (NIH HEAL Initiative) active
CTN-0079 Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) completed
CTN-0079-A-1: Emergency Department Outcomes for Patients with Opioid Use Disorder (Project ACT) (NIH HEAL Initiative) completed
CTN-0078-Ot Knowledge of and Attitudes about Medication Assisted Treatment within American Indian Communities completed
CTN-0077-Ot Medical Cannabis Use Among Primary Care Patients: Using Electronic Health Records to Study Large Populations completed
CTN-0076-Ot Clinical Decision Support for Opioid Use Disorders in Medical Settings: Pilot Usability Testing in an EMR (COMPUTE) completed
CTN-0075 Physician-Pharmacist Collaboration in the Management of Patients with Opioid Use Disorder completed
CTN-0074 Primary Care Opioid Use Disorders (PROUD) Treatment Trial completed
CTN-0074-A-1: Primary Care Opioid Use Disorders Treatment Trial Economic Analysis Study (NIH HEAL Initiative) completed
CTN-0073-Ot Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network completed
CTN-0072-Ot Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance Across Health Systems completed
CTN-0071-Ot Electronic Health Records Data Elements Research (EHR-DARE) completed
CTN-0070-Ot Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot completed
CTN-0069 Opioid Use Disorder in the Emergency Department completed
CTN-0069-A-1: Retrospective Evaluation of Rapid Buprenorphine Induction in the Emergency Department for Opioid Use Disorder completed
CTN-0069-A-2: The Impact of COVID-19 on Individuals with Opioid Use Disorder Who Received Emergency Department Care: A Survey Study of Project ED Health Participants and Medical Leadership at Four EDs completed
CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder completed
CTN-0067 Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES): Scale-Up completed
CTN-0066-Ot Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems completed
CTN-0065-Ot Evaluation of Drug Screening Implementation in Primary Care completed
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care Among HIV/HCV Co-Infected Substance Users completed
CTN-0064-A-1: Determination of Cause of Death Among HIV-Infected Substance Users Enrolled in Project Hope: A 4 Year Follow-Up completed
CTN-0063-S Gender Differences in the Interrelationships Between Sexual Abuse, Risky Sexual Behavior, and Anxiety-Depression in Treatment Efficacy and Drug Use Over Time Among Individuals with Substance Use Disorders completed
CTN-0062-Ot A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings (CDE-EHR-PC) completed
CTN-0062-Ot-A-1: Implementing the Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS) Tool in Rural Federally-Qualified Health Centers: An Ancillary Study of the CDE-EHR-PC Study completed
CTN-0061-Ot Kaiser Virtual Data Warehouse — Prescription Opioid Users completed
CTN-0060-A-1 Validating 3 Substance Use Screening Tools for Adolescents completed
CTN-0059 Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief Screen/Assessment Tool (TAPS Tool) completed
CTN-0057-Ot Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC) completed
CTN-0056-Ot Testing and Linkage to HIV Care in China: A Cluster Randomized Trial completed
CTN-0055 Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES) completed
CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) for Methamphetamine Use Disorder completed
CTN-0053 Achieving Cannabis Cessation -- Evaluating N-Acetylcysteine Treatment (ACCENT) completed
CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) completed
CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) completed
CTN-0051-A-1: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study completed
CTN-0051-A-2: Treatment-As-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with CTN-0051 completed
CTN-0050 Long Term Follow-Up of START Patients completed
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users completed
CTN-0049-A-1: Examining the Patient Navigation Process for HIV and Substance Abuse Treatment completed
CTN-0049-A-2: Utilization of the Electronic Medical Record to Assess and Predict 3-Day Readmission Risk Among HIV-Infected Inpatients Enrolled in CTN-0049 completed
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB) completed
CTN-0048-A-1: Pharmacogenetics of Buprenorphine/Naltrexone for Cocaine Dependence in CURB Study completed
CTN-0047 Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department completed
CTN-0047-A-1: Site Influences on Treatment Effects – Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) completed
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence completed
CTN-0046-A-1: Site Influences on Treatment Effects – Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependence Outcome completed
CTN-0045-Ot Rates of HIV Testing and Barriers to Testing in African Americans Receiving Substance Abuse Treatment completed
CTN-0044 Web Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders completed
CTN-0044-A-1: Site Influences on Treatment Effects – Web-Delivery of Evidence-Based Psychosocial Treatment for Substance Use Disorders completed
CTN-0044-A-2: Acceptability of a Web-Delivered, Evidence-Based, Psychosocial Intervention Among Individuals with Substance Use Disorders Who Identify as American Indian/Alaska Native completed
CTN-0044-A-3: Web-Tx Organizational and Practitioner Follow-Up completed
CTN-0043-S Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations completed
CTN-0042-S Efficacy of Motivational Enhancement Therapy for African Americans completed
CTN-0041-S Relationships Between Demographic Characteristics of Patients and Therapists, Measures of Therapeutic Process and Therapeutic Alliance, and Outcomes completed
CTN-0040-S Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug Abusing/Dependent Participants completed
CTN-0039-S Gender Differences in the Prevalence and Predictors of HIV Risk Behaviors completed
CTN-0038-Ot Barriers to Substance Abuse Treatment Among Asian Americans and Pacific Islanders completed
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) completed
CTN-0037-A-1: Site Influences on Treatment Effects – Exercise as a Treatment for Substance Use Disorders completed
CTN-0036-Ot Epidemiology and Ethnographic Survey of “Cheese” Heroin Use among Hispanics in Dallas County completed
CTN-0035-Ot Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment completed
CTN-0034-Ot Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives completed
CTN-0033-Ot Methamphetamine Use Among American Indians completed
CTN-0033-Ot-1: Methamphetamine Use Among American Indians completed
CTN-0033-Ot-2: Methamphetamine Use and Treatment in Native American Communities in the Southwest completed
CTN-0033-Ot-3: Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers? completed
CTN-0033-Ot-4: An Exploration of Methamphetamine and Other Drug Use and Treatment Options Among Urban and Rural Northern Plains American Indians completed
CTN-0033-Ot-5: The Choctaw Nation Methamphetamine Data Needs Project completed
CTN-0032 HIV Rapid Testing and Counseling completed
CTN-0032-A-1: Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs completed
Project Aware: Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. — An Adaptation of CTN-0032 completed
CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement completed
CTN-0031-A-1: An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers completed
CTN-0031-A-2: The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study completed
CTN-0031-A-3: Organizational and Practitioner Influences on Implementation of STAGE-12 completed
CTN-0030 Prescription Opioid Addiction Treatment Study (POATS) completed
CTN-0030-A-1: Collection of Economic Data for the Prescription Opioid Addiction Treatment Study completed
CTN-0030-A-2: Effects of Chronic Opioids on the Brain completed
CTN-0030-A-3: Protocol Amendment to Examine Long-Term Outcomes completed
CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD completed
CTN-0028 Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders completed
CTN-0028-A-1: Does Methylphenidate Treatment for ADHD Increase the Rate of Smoking in Adolescents with Comorbid ADHD, Substance Use Disorder, and Nicotine Dependence? completed
CTN-0027 Starting Treatment with Agonist Replacement Therapies (START) completed
CTN-0027-A-1: START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies completed
CTN-0027-A-2: Retention of Suboxone Patients in START: Perspectives of Providers and Patients completed
CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcomes for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse completed
CTN-0020 Job Seekers Training for Patients with Drug Dependence completed
CTN-0020-A-1: Job Seekers’ Training for Clients/Relatives with Drug Dependence (Specific to the Na’Nizhoozhi Center, Inc.) completed
CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment completed
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment completed
CTN-0017 HIV and HCV Intervention in Drug Treatment Settings completed
CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings completed
CTN-0015 Women’s Treatment for Trauma and Substance Use Disorders completed
CTN-0015-A-1: Survey of Eating Disorder Symptoms among Women in Treatment for Substance Abuse Disorders completed
CTN-0014 Brief Strategic Family Therapy for Adolescent Drug Abusers completed
CTN-0014-A-1: Mediators and Moderators of BSFT for Adolescent Drug Use completed
CTN-0013 Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users completed
CTN-0013-A-1: Trauma and Intravenous Drug Use among Pregnant Alcohol/Other Drug Abusing Women: Factors in Predicting Child Abuse Potential completed
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs completed
CTN-0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities completed
CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults completed
CTN-0010-A-1: Cost-Effective Analysis (CEA) in the CTN: Bup/Nal Treatment for Opioid Addicted Youth completed
CTN-0010-A-2: Comorbid Conditions in Adolescents with Opioid versus Alcohol/Marijuana Use Disorders completed
CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs completed
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation completed
CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics completed
CTN-0007-A-1: Survey of Counselor’s Perceptions of Incentive Programs completed
CTN-0007-A-2: Economic Evaluations in the CTN — Methods & Applications completed
CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics completed
CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse completed
CTN-0004 MET (Motivational Enhancement Treatment) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse completed
CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules completed
CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification completed
CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification completed